Biggest News Aggregation in the World
📰 Immune News

Page 36 - Immune News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Immune. Real-time updates on events, politics, business and more.

Allogene Therapeutics Presents Interim Phase 1 Data on ALLO-316 in Renal Cell Carcinoma at the American Association of Cancer Research (AACR) Annual Meeting

Data Provide Proof-of-Concept for an Allogeneic Anti-CD70 CAR T Candidate in Patients with Renal Cell Carcinoma Who Received Prior Immune Checkpoint Inhibitor and VEGF-Targeting TherapySingle... | April 17, 2023
United States Allogene Allo Christine Cassiano Zachary Roberts Samera Srour University Of Texas Md Anderson Cancer Center

MSNBC Morning Joe Weekend June 4, 2024 10:08:00

Particular interest of ours is none other than who? donald trump because you would not have thi level of interference, but for donald trump if its anyone else, theyre gonna be hard-pressed to mak the case for why they are doin and saying things with respect to this prosecution. and so, again it is a furthe example at all levels, all factions of our society are no immune to this infection it is our judicial system, i is our political syste obviously, our economic system and certainly our internat...
Donald Trump Anyone Else Internationa Relationships Thi Point Ow Regimes Tha Authority

Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses

Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic preclinical model in vivo, including following tumor cell... | April 13, 2023
United Kingdom Steve Harr Immunocompetent Allogeneic Sana Biotechnology Inc Company Securities Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Sana Biotechnology Announces Preclinical Data Published in Science Translational Medicine Showing its Hypoimmune Pancreatic Islet Cells Evaded Allogeneic and Autoimmune Rejection and Controlled Type 1 Diabetes in Preclinical Model

Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by the immune system Similar hypoimmune primary human... | April 12, 2023
United Kingdom Steve Harr Exchange Commission Sana Biotechnology Inc Company Securities Science Translational Medicine

Yumanity Therapeutics : VISTA blocking immunotherapy engineered to address immunosuppression in the tumor microenvironment (TME) Phase 1 initial data readout anticipated by end of 2023 - Form 8-K

Kineta, Inc. , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today the first patient has been... | April 12, 2023
United States Shawn Iadonato Evan Yu Jacques Bouchy John Mullaly Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science